Drug Company Seeks Review Of Cancer Treatment Patent, Joinder With Other Case
(January 18, 2018, 3:45 PM EST) -- ALEXANDRIA, Va. —West-Ward Pharmaceutical Co. on Jan. 17 took aim at a cancer treatment patent while also requesting joinder to an inter partes review (IPR) by Breckenridge Pharmaceutical Inc., in which...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login